Mert Başaran

1.3k total citations
85 papers, 952 citations indexed

About

Mert Başaran is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Mert Başaran has authored 85 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 27 papers in Surgery. Recurrent topics in Mert Başaran's work include Sarcoma Diagnosis and Treatment (19 papers), Lymphoma Diagnosis and Treatment (16 papers) and Renal cell carcinoma treatment (12 papers). Mert Başaran is often cited by papers focused on Sarcoma Diagnosis and Treatment (19 papers), Lymphoma Diagnosis and Treatment (16 papers) and Renal cell carcinoma treatment (12 papers). Mert Başaran collaborates with scholars based in Türkiye, Germany and Italy. Mert Başaran's co-authors include Burak Sakar, Erkan Topuz, Adnan Aydıner, Faruk Taş, Hakan Çamlıca, Yeşim Eralp, Sevil Bavbek, Bilge Bılgıç, Zeki Üstüner and Andaç Argon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mert Başaran

80 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mert Başaran Türkiye 18 389 304 222 138 130 85 952
Riccardo Valli Italy 18 304 0.8× 301 1.0× 297 1.3× 141 1.0× 152 1.2× 66 974
Maristella Saponara Italy 20 640 1.6× 255 0.8× 350 1.6× 182 1.3× 94 0.7× 70 1.2k
Tatsuru Ikeda Japan 17 310 0.8× 216 0.7× 213 1.0× 306 2.2× 86 0.7× 56 1.2k
Ruth Achten Belgium 17 116 0.3× 254 0.8× 205 0.9× 143 1.0× 401 3.1× 34 1.1k
Garry Forgeson New Zealand 14 229 0.6× 494 1.6× 175 0.8× 196 1.4× 174 1.3× 22 918
Emanuele Naglieri Italy 15 200 0.5× 336 1.1× 245 1.1× 210 1.5× 77 0.6× 42 1.0k
C. Martin France 9 365 0.9× 352 1.2× 163 0.7× 60 0.4× 380 2.9× 13 894
Suk Joong Oh South Korea 16 423 1.1× 539 1.8× 263 1.2× 145 1.1× 263 2.0× 40 1.0k
Haiyan Wang China 14 320 0.8× 227 0.7× 85 0.4× 159 1.2× 149 1.1× 54 939
Francesca Del Monte Italy 17 168 0.4× 458 1.5× 101 0.5× 306 2.2× 91 0.7× 27 1.0k

Countries citing papers authored by Mert Başaran

Since Specialization
Citations

This map shows the geographic impact of Mert Başaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mert Başaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mert Başaran more than expected).

Fields of papers citing papers by Mert Başaran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mert Başaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mert Başaran. The network helps show where Mert Başaran may publish in the future.

Co-authorship network of co-authors of Mert Başaran

This figure shows the co-authorship network connecting the top 25 collaborators of Mert Başaran. A scholar is included among the top collaborators of Mert Başaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mert Başaran. Mert Başaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuyumcu, Serkan, et al.. (2025). Impact of extended [177Lu] Lu-PSMA-617 therapy on absorbed kidney dose and CKD-EPI values: how long can therapy be safely continued?. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3135–3144. 3 indexed citations
2.
Arslan, Çağatay, Mert Başaran, İrfan Çiçin, et al.. (2024). Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer. JCO Global Oncology. 10(10). e2400201–e2400201. 1 indexed citations
3.
Karadeniz, Ahmet, et al.. (2023). Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort. Journal of Chemotherapy. 36(2). 133–142. 1 indexed citations
4.
Başaran, Mert, et al.. (2022). Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma. Journal of Chemotherapy. 35(4). 343–347. 4 indexed citations
5.
Yılmaz, Ebru Arık, Zeynep Gözde Özkan, Arzu Poyanlı, et al.. (2020). Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?. Nuclear Medicine Communications. 41(12). 1242–1249. 7 indexed citations
6.
Başaran, Mert, et al.. (2017). 22-year survival following radical nephrectomy and several metastasectomies in a case of renal cell carcinoma. SHILAP Revista de lepidopterología. 43(2). 216–219. 3 indexed citations
7.
Tuncer, Samuray, et al.. (2014). Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience. Current Eye Research. 40(8). 780–785. 33 indexed citations
8.
Başaran, Mert, Mazhar Müslüm Tuna, Berçem Ayçıçek Doğan, et al.. (2014). Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family. Journal of Endocrinological Investigation. 38(5). 541–546. 3 indexed citations
9.
Yıldız, İbrahim, Fatma Şen, Meltem Ekenel, et al.. (2013). Prognostic Factors Associated with the Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma. Current Oncology. 20(6). 546–553. 12 indexed citations
10.
Keskın, Serkan, Meltem Ekenel, Mert Başaran, & Sevil Bavbek. (2011). Predictive Value of Marker Half-life in Relapsed and Nonrelapsed Nonseminomatous Germ Cell Testicular Tumor Patients Undergoing Chemotherapy. American Journal of Clinical Oncology. 35(4). 369–372. 12 indexed citations
11.
Keskın, Serkan, Meltem Ekenel, Mert Başaran, & Sevil Bavbek. (2011). Surveillance Results of Patients with Stage I Nonseminomatous Germ Cell Testicular Cancer. Onkologie. 34(4). 173–176. 2 indexed citations
12.
Özger, Harzem, Levent Eralp, Ata Can Atalar, et al.. (2007). [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].. PubMed. 41(3). 211–9. 11 indexed citations
13.
Başaran, Mert, et al.. (2007). Human immunodeficiency virus-negative tonsil Kaposi's sarcoma and Hodgkin's disease: case report and review of the literature.. PubMed. 9(3). 321–4. 2 indexed citations
14.
Taş, Faruk, Zeki Üstüner, Gülbeyaz Can, et al.. (2005). The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncologica. 44(2). 161–167. 66 indexed citations
15.
Ağaoğlu, Fulya, Merdan Fayda, Yavuz Dizdar, et al.. (2005). Primary uterine lymphoma: Case report and literature review. Australian and New Zealand Journal of Obstetrics and Gynaecology. 45(1). 88–89. 6 indexed citations
16.
Yazar, Aziz, Mert Başaran, Yavuz Dizdar, et al.. (2004). Relapse of non‐Hodgkin's lymphoma confined to the corpus uteri. Australian and New Zealand Journal of Obstetrics and Gynaecology. 44(3). 273–274. 1 indexed citations
17.
Üstüner, Zeki, Mert Başaran, Talat Kırış, et al.. (2004). Skull Base Plasmacytoma in a Patient with Light Chain Myeloma. Skull base. 13(3). 167–172. 33 indexed citations
18.
Uygun, Kazım, Adnan Aydıner, Pınar Saip, et al.. (2003). Granulosa Cell Tumor of the Ovary. American Journal of Clinical Oncology. 26(5). 517–521. 50 indexed citations
19.
Uygun, Kazım, Adnan Aydıner, Pınar Saip, et al.. (2003). Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecologic Oncology. 88(3). 400–403. 38 indexed citations
20.
Başaran, Mert, Sevil Bavbek, İbrahim Güllü, et al.. (2002). A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent or Metastatic Head and Neck Cancer. Journal of Chemotherapy. 14(2). 207–213. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riccardo Valli Breakdown of academic impact, for papers by Maristella Saponara Breakdown of academic impact, for papers by Tatsuru Ikeda Breakdown of academic impact, for papers by Ruth Achten Breakdown of academic impact, for papers by Garry Forgeson Breakdown of academic impact, for papers by Emanuele Naglieri Breakdown of academic impact, for papers by C. Martin Breakdown of academic impact, for papers by Suk Joong Oh Breakdown of academic impact, for papers by Haiyan Wang Breakdown of academic impact, for papers by Francesca Del Monte
Rankless by CCL
2026